Stockscreener 앱 받기
23.43
2.00%
0.46
전일 마감가:
$22.97
열려 있는:
$22.98
하루 거래량:
161.07K
Relative Volume:
0.64
시가총액:
$724.28M
수익:
$290.71M
순이익/손실:
$-163.43M
주가수익비율:
-4.2755
EPS:
-5.48
순현금흐름:
$11.70M
1주 성능:
-0.04%
1개월 성능:
-17.38%
6개월 성능:
+7.63%
1년 성능:
+38.97%
1일 변동 폭
$22.91
$23.50
1주일 범위
$22.39
$23.58
52주 변동 폭
$14.76
$31.04
Fulgent Genetics Inc Stock (FLGT) Company Profile
명칭
Fulgent Genetics Inc
전화
626-350-0537
주소
4399 SANTA ANITA AVE, EL MONTE
Compare FLGT vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
23.43 | 710.06M | 290.71M | -163.43M | 11.70M | -5.48 |
|
TMO
Thermo Fisher Scientific Inc
|
504.82 | 191.54B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
212.58 | 151.94B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
629.35 | 49.28B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
125.81 | 35.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
323.37 | 31.37B | 3.17B | 642.63M | 539.81M | 10.77 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-05 | 업그레이드 | UBS | Neutral → Buy |
| 2023-12-07 | 개시 | UBS | Neutral |
| 2022-12-08 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-11-18 | 개시 | Raymond James | Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-02-04 | 재개 | Piper Sandler | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Underperform |
| 2021-01-08 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2020-11-24 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-08-20 | 개시 | Oppenheimer | Outperform |
| 2020-05-29 | 개시 | BTIG Research | Buy |
| 2019-11-05 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2018-03-01 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-11-07 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
모두보기
Fulgent Genetics Inc 주식(FLGT)의 최신 뉴스
Allianz Asset Management GmbH Increases Stake in Fulgent Genetics, Inc. $FLGT - Defense World
Fulgent Genetics, Inc. (FLGT) Stock Analysis: Exploring a 46% Potential Upside Amid Diagnostic and Therapeutic Growth - DirectorsTalk Interviews
Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026 - Caledonian Record
Fulgent Genetics (NASDAQ:FLGT) Cut to Hold at Zacks Research - Defense World
Fulgent Genetics (NASDAQ:FLGT) Stock Rating Lowered by Zacks Research - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) versus Privia Health Group (NASDAQ:PRVA) Critical Contrast - Defense World
What’s the analyst consensus on Fulgent Genetics Inc.2025 Technical Patterns & Weekly Top Gainers Alerts - mfd.ru
FLGT to acquire Bako & StrataDx assets to expand pathology platform - MSN
Fulgent Genetics, Inc. (NASDAQ:FLGT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
(FLGT) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Is Fulgent Genetics (NASDAQ:FLGT) A Risky Investment? - 富途牛牛
What Does The Institutional Ownership Tell Us About Fulgent Genetics? - simplywall.st
Esoteric Testing Research Report 2026 - GlobeNewswire Inc.
Fulgent Genetics: The Price Has Caught Up To Value, But I Still Like The Stock - Seeking Alpha
Breakout Move: Is Fulgent Genetics Inc a momentum stockMarket Performance Report & Accurate Intraday Trading Signals - baoquankhu1.vn
(FLGT) Risk Channels and Responsive Allocation - Stock Traders Daily
Market Review: What is the long term forecast for Fulgent Genetics Inc stock2025 Earnings Surprises & Low Risk Entry Point Tips - baoquankhu1.vn
Published on: 2026-01-19 16:33:56 - baoquankhu1.vn
Fulgent Genetics, Inc. (NASDAQ:FLGT) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Buyout Rumor: Why Fulgent Genetics Inc stock remains undervaluedWatch List & Fast Entry and Exit Trade Plans - Bộ Nội Vụ
Why Fulgent Genetics Inc stock remains undervalued2025 Key Highlights & Community Consensus Trade Alerts - Bộ Nội Vụ
Fulgent Genetics, Inc. (NASDAQ:FLGT) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Analysis Recap: Is ESEA stock a falling knife or bargain buy2025 Key Highlights & Smart Swing Trading Techniques - baoquankhu1.vn
Fulgent Will Acquire Two Laboratories - labusinessjournal.com
(FLGT) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Will Fulgent Genetics Inc. stock continue dividend increasesEarnings Miss & Reliable Intraday Trade Plans - Улправда
How to contact the Daily Bulletin - FinancialContent
Will Fulgent Genetics Inc. stock maintain dividend yieldBreakout Watch & Smart Money Movement Alerts - ulpravda.ru
Fulgent Genetics, Inc.Common Stock (NQ: FLGT - FinancialContent
How strong is Fulgent Genetics Inc. stock revenue growthCPI Data & Low Risk High Win Rate Picks - ulpravda.ru
Is Fulgent Genetics Inc. (7F0) stock cheap by valuation metrics2025 Bull vs Bear & Long-Term Growth Portfolio Plans - ulpravda.ru
Aug Weekly: Is Fulgent Genetics Inc. (7F0) stock cheap by valuation metricsTrade Entry Report & Free Technical Pattern Based Buy Signals - ulpravda.ru
Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Large Institutional Owners Must Be Happy as Stock Continues to Impress, up 6.6% Over the Past Week - 富途牛牛
Is Fulgent Genetics Inc. (7F0) stock a fit for income portfoliosWeekly Trend Summary & Weekly Watchlist for Hot Stocks - ulpravda.ru
Health Check: How Prudently Does Fulgent Genetics (NASDAQ:FLGT) Use Debt? - simplywall.st
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022. - MarketScreener
Fulgent Genetics (NASDAQ:FLGT) Stock Price Up 7.3%Time to Buy? - MarketBeat
Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue Estimates - MSN
How Fulgent Genetics Inc. stock performs in stagflation2026 world cup usa national team quarterfinals defensive leaders high defensive line match prediction breakdown - Улправда
Fulgent Genetics (NASDAQ:FLGT) vs. Mitesco (OTCMKTS:MITI) Critical Analysis - Defense World
Liquidity Mapping Around (FLGT) Price Events - Stock Traders Daily
Squarepoint Ops LLC Cuts Position in Fulgent Genetics, Inc. $FLGT - MarketBeat
FLGT to Acquire Bako & StrataDx Assets to Expand Pathology Platform - Finviz
Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx - BioSpace
Fulgent Genetics to acquire StrataDx and selected assets of Bako Diagnostics - Medical Buyer
Fulgent Genetics to acquire select assets of Bako Diagnostics and StrataDx for $55.5m - pehub.com
Fulgent Genetics to buy Bako Diagnostics assets and StrataDx - Yahoo Finance
Latham & Watkins Advises on Fulgent Genetics’ Acquisition of Bako Diagnostics and StrataDX - Legal Desire Media and Insights
Fulgent Genetics to Acquire Bako Diagnostics and StrataDx - citybiz
Fulgent Genetics to acquire Bako Diagnostics and StrataDx for $55.5 million - Investing.com Nigeria
Fulgent Genetics to acquire Bako Diagnostics and StrataDx for $55.5 million By Investing.com - Investing.com South Africa
Fulgent Genetics Inc (FLGT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
1.13%
자본화:
|
볼륨(24시간):